Expression of TIMP3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

TIMP3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 115.27

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

109.4

Number of samples

141

Samples

Sample	Description	TPM
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	383.5
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	342.9
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	330.0
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	304.1
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	262.5
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	249.5
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	247.3
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	240.5
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	236.8
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	232.3
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	217.0
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	214.7
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	212.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	212.1
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	201.4
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	199.4
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	199.2
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	193.9
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	193.5
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	189.8
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	186.1
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	186.0
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	181.1
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	178.3
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	176.7
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	176.3
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	174.0
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	162.4
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	158.5
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	153.7
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	153.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	153.0
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	152.6
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	147.3
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	143.9
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	143.1
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	138.5
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	138.4
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	136.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	135.6
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	135.0
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	131.9
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	126.8
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	125.8
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	123.9
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	121.2
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	118.8
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	118.5
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	117.2
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	115.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	115.5
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	115.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	114.6
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	114.0
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	112.3
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	111.5
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	110.9
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	110.3
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	109.8
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	108.2
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	106.8
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	106.4
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	106.3
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	104.5
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	102.2
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	96.5
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	96.0
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	93.7
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	92.2
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	92.0
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	89.6
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	89.4
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	89.1
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	88.5
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	87.8
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	86.5
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	85.1
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	84.2
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	81.7
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	81.5
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	80.5
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	79.6
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	78.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	77.9
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	77.4
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	77.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	76.6
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	75.5
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	75.3
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	72.9
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	71.2
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	70.2
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	68.5
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	68.4
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	66.6
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	65.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	63.2
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	62.1
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	61.5
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	61.3
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	60.3
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	59.6
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	58.7
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	58.5
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	58.3
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	58.3
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	56.5
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	53.9
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	52.9
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	51.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	50.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	50.3
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	50.2
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	49.7
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	49.5
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	47.4
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	46.9
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	46.6
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	46.6
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	46.0
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	45.4
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	45.2
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	45.0
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	43.2
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	40.7
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	39.6
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	37.0
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	36.7
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	34.4
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	33.4
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	33.2
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	32.5
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	32.2
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	29.1
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	29.0
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	26.8
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	24.3
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	23.5
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	23.4
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	23.3
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	23.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

TIMP3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 68.69

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

83.3

Number of samples

Samples

Sample	Description	TPM
AK076	N, NA, stage:NA, alive, 660 days	345.4
AK100	N, NA, stage:NA, alive, 960 days	190.2
AK178	N, NA, stage:NA, dead, 240 days	169.8
AK089	N, NA, stage:NA, dead, 330 days	156.5
AK117	N, NA, stage:NA, dead, 210 days	154.6
AK079	N, NA, stage:NA, dead, 210 days	149.3
AK098	N, NA, stage:NA, dead, 660 days	134.2
AK226	N, NA, stage:NA, dead, 360 days	133.7
AK124	N, NA, stage:NA, alive, 1920 days	133.6
AK183	N, NA, stage:NA, alive, 360 days	132.7
AK133	N, NA, stage:NA, dead, 360 days	129.6
AK158	N, NA, stage:NA, dead, 360 days	117.0
AK199	N, NA, stage:NA, alive, 1860 days	116.6
AK103	N, NA, stage:NA, alive, 1320 days	111.5
AK066	N, NA, stage:NA, alive, 960 days	101.4
AK035	N, NA, stage:NA, dead, 210 days	98.9
AK188	N, NA, stage:NA, alive, 420 days	95.0
AK218	N, NA, stage:NA, dead, 180 days	87.1
AK071	N, NA, stage:NA, dead, 540 days	86.5
AK091	N, NA, stage:NA, dead, 210 days	86.3
AK102	N, NA, stage:NA, alive, 1740 days	84.7
AK055	N, NA, stage:NA, dead, 240 days	82.9
AK149	N, NA, stage:NA, dead, 420 days	82.4
AK195	N, NA, stage:NA, dead, 390 days	80.2
AK053	N, NA, stage:NA, dead, 300 days	78.7
AK041	N, NA, stage:NA, alive, 810 days	77.6
AK099	N, NA, stage:NA, dead, 420 days	74.7
AK134	N, NA, stage:NA, dead, 360 days	69.5
AK068	N, NA, stage:NA, alive, 360 days	69.4
AK074	N, NA, stage:NA, alive, 300 days	69.1
AK165	N, NA, stage:NA, alive, 360 days	68.7
AK231	N, NA, stage:NA, dead, 240 days	68.7
AK173	N, NA, stage:NA, dead, 180 days	66.8
AK072	N, NA, stage:NA, dead, 150 days	65.6
AK003	N, NA, stage:NA, dead, 600 days	62.9
AK139	N, NA, stage:NA, dead, 270 days	62.5
AK030	N, NA, stage:NA, dead, 120 days	61.4
AK015	N, NA, stage:NA, alive, 720 days	59.3
AK185	N, NA, stage:NA, alive, 330 days	58.0
AK167	N, NA, stage:NA, dead, 180 days	56.9
AK088	N, NA, stage:NA, dead, 360 days	55.4
AK123	N, NA, stage:NA, dead, 180 days	49.5
AK213	N, NA, stage:NA, alive, 2010 days	48.7
AK205	N, NA, stage:NA, dead, 120 days	48.4
AK227	N, NA, stage:NA, alive, 300 days	46.8
AK005	N, NA, stage:NA, dead, 240 days	43.7
AK002	N, NA, stage:NA, dead, 570 days	43.3
AK085	N, NA, stage:NA, alive, 660 days	41.6
AK216	N, NA, stage:NA, dead, 360 days	40.6
AK049	N, NA, stage:NA, dead, 180 days	40.0
AK236	N, NA, stage:NA, dead, 360 days	36.8
AK051	N, NA, stage:NA, dead, 360 days	33.9
AK142	N, NA, stage:NA, alive, 90 days	33.8
AK156	N, NA, stage:NA, dead, 330 days	33.2
AK081	N, NA, stage:NA, dead, 180 days	32.3
AK153	N, NA, stage:NA, dead, 240 days	31.0
AK006	N, NA, stage:NA, dead, 360 days	28.8
AK043	N, NA, stage:NA, alive, 660 days	17.2
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0225760003	Tumor	2.0
CPT0087730003	Tumor	1.3
CPT0205570003	Tumor	1.2
CPT0189750004	Tumor	0.9
CPT0218670003	Tumor	0.8
CPT0206880003	Tumor	0.8
CPT0199770003	Tumor	0.7
CPT0127480003	Tumor	0.7
CPT0217060003	Tumor	0.7
CPT0087680003	Tumor	0.7
CPT0218830004	Tumor	0.6
CPT0218960004	Tumor	0.6
CPT0087570003	Tumor	0.6
CPT0189460003	Tumor	0.6
CPT0127420003	Tumor	0.5
CPT0171580008	Tumor	0.5
CPT0224390004	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0125220003	Tumor	0.5
CPT0093510003	Tumor	0.5
CPT0217880003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0168480003	Tumor	0.4
CPT0087950003	Tumor	0.4
CPT0168080003	Tumor	0.3
CPT0189850004	Tumor	0.3
CPT0002410011	Tumor	0.3
CPT0208980003	Tumor	0.3
CPT0182580003	Tumor	0.3
CPT0123530003	Tumor	0.3
CPT0206450003	Tumor	0.3
CPT0168380003	Tumor	0.3
CPT0207090003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0092440003	Tumor	0.2
CPT0224600003	Tumor	0.2
CPT0217190003	Tumor	0.2
CPT0162100003	Tumor	0.1
CPT0104220003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0228220003	Tumor	0.1
CPT0206330003	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0125510003	Tumor	0.1
CPT0167530003	Tumor	0.1
CPT0218770003	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0217430008	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0168830003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0162140003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0175060003	Tumor	0.0
CPT0089150003	Tumor	0.0
CPT0190240004	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0078580003	Tumor	0.0
CPT0064890003	Tumor	-0.1
CPT0186100003	Tumor	-0.1
CPT0189250003	Tumor	-0.1
CPT0224540004	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0218330004	Tumor	-0.1
CPT0224330003	Tumor	-0.1
CPT0189650004	Tumor	-0.1
CPT0162020003	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0218890004	Tumor	-0.2
CPT0204410003	Normal	-0.2
CPT0206670004	Tumor	-0.2
CPT0219080004	Tumor	-0.2
CPT0161730003	Tumor	-0.2
CPT0168720003	Tumor	-0.2
CPT0204420003	Normal	-0.3
CPT0190360004	Tumor	-0.3
CPT0093450003	Tumor	-0.3
CPT0204360003	Normal	-0.3
CPT0093550003	Tumor	-0.3
CPT0204350003	Normal	-0.3
CPT0225730003	Tumor	-0.3
CPT0204380003	Normal	-0.4
CPT0167640003	Tumor	-0.4
CPT0206230003	Tumor	-0.4
CPT0204400003	Normal	-0.4
CPT0217710008	Tumor	-0.4
CPT0209440003	Tumor	-0.5
CPT0189570004	Tumor	-0.5
CPT0167970003	Tumor	-0.5
CPT0205780003	Tumor	-0.5
CPT0201710003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0207030003	Tumor	-0.5
CPT0204330003	Normal	-0.6
CPT0104330003	Tumor	-0.6
CPT0093360003	Tumor	-0.6
CPT0071100003	Tumor	-0.6
CPT0216920008	Tumor	-0.6
CPT0182550003	Tumor	-0.7
CPT0125570003	Tumor	-0.7
CPT0205450004	Tumor	-0.7
CPT0204370003	Normal	-0.7
CPT0206560003	Tumor	-1.1
CPT0204390003	Normal	-1.1
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis